Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Recruiting 5Terminated 2Withdrawn 1Unknown 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Tuberous Sclerosis 2Vascular Malformations 1Triple Negative Breast Neoplasms 1Peutz-Jeghers Syndrome 1Perivascular Epithelioid Cell Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Malignant Solid Tumors 1Lymphangioma 1Lymphangioleiomyomatosis 1Leiomyoma 1Kaposiform Hemangioendothelioma 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Hemangioendothelioma 1Graft vs Host Disease 1Epilepsy 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 6fludarabine 5Exercise 4Blood Specimen Collection 4Surveys and Questionnaires 3Immunotherapy, Adoptive 3thymoglobulin 2pegylated granulocyte colony-stimulating factor 2Voriconazole 2Stem Cell Transplantation 2Saline Solution 2Physical Therapy Modalities 2Parenteral Nutrition 2Mycophenolic Acid 2Etoposide 2Cytarabine 2CF regimen 2BNT162 Vaccine 2Azacitidine 2venetoclax 1trihexyltetradecylphosphonium chloride 1treosulfan 1shengxuening 1ruxolitinib 1ramosetron 1monalizumab 1glucarpidase 1fludarabine phosphate 1ferrous succinate 1eltrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hematologic Neoplasms × Sirolimus × Clear all
NCT01428973 2024-05-09

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

University of Liege

Phase 2 Unknown
200 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡